Toxic fragments in post-mortem brain from SCA3 patients
- Conditions
- Spinocerebellar Ataxia Type 3
- Registration Number
- DRKS00017787
- Lead Sponsor
- Institut für Medizinische Genetik u. Angew. Genomik
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Enrolling by invitation
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Patients are diagnosed as SCA3
post-mortem brain available
controls did not died at a neurodegenerative disease
Exclusion Criteria
no consent given to use post-mortem brain for research
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Detection of specific fragments in the brain yes/no
- Secondary Outcome Measures
Name Time Method possible to use this as potential biomarker yes/no